Surya Pharmaceutical Limited - Company Profile

Q: Who are the current directors of Surya Pharmaceutical Limited?

The current directors of Surya Pharmaceutical Limited are Bharat Bhushan Jain, Jasvinder Singh, Rajiv Goyal, Alka Goyal, Bharat Jain.

It is a healthcare public limited company based in Delhi, Delhi, India, established in 1992.

1992 Delhi, Delhi, India Under Liquidation

Last Updated: June 24, 2025

Access Report

About Surya Pharmaceutical Limited

Surya Pharmaceutical Limited, a under liquidation public limited company, was established on 25 March 1992 in Delhi, Delhi, India. Engaging in ayurvedic products & services within the healthcare sector, it holds CIN: L24232DL1992PLC227186. Registered under ROC Roc Delhi. it is listed. It has an authorized capital of ₹100.00 Cr and a paid-up capital of ₹20.28 Cr.

It upholds a active non-compliant status. Its leadership includes Bharat Bhushan Jain (Company Secretary), Jasvinder Singh (Additional Director), Rajiv Goyal (Managing Director). Past directors included Manohar Lal Sharma, Haribhajan Lal Vohra, Abhishek Arya. It holds ₹4,828.13 Cr open charges and ₹1,682.69 Cr settled loans. Its latest AGM occurred on 29 September 2014, with the balance sheet filed on 31 March 2014. It is based at 1596 , 1St Floor Bhagirath Palace , Chandni Chownk, Delhi, Delhi, 110006.

Company Details

CIN/LLPIN
L24232DL1992PLC227186
Registration Number
227186
Incorporation Date
25 March 1992
Authorized Capital
₹100.00 Cr
Paid-Up Capital
₹20.28 Cr
ROC Code
Roc Delhi
Listing Status
Listed
Company Status
Under Liquidation

Key Metrics

Authorised Capital ₹ 100.00 Cr as on 24-06-2025
Paid Up Capital ₹ 20.28 Cr as on 24-06-2025
Company Age 33 Year, 10 Months
Last Filing with ROC 31 Mar 2014
Open Charges ₹ 4,828.13 Cr as on 24-06-2025
Satisfied Charges ₹ 1,682.69 Cr as on 24-06-2025

Comprehensive Company Insights

Explore comprehensive insights into Surya Pharmaceutical Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Surya Pharmaceutical Limited?

Current Directors

Name	Designation	Appointment Date	Status
Bharat Bhushan Jain	Company Secretary	16 Jun 2012	Current
Jasvinder Singh	Additional Director	10 Oct 2013	Current
Rajiv Goyal	Managing Director	25 Mar 1992	Current
Alka Goyal	Whole-Time Director	24 Aug 1996	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	23 Jul 2011	Past
Pramod Abcsdd	Director	04 Mar 2012	Past
Pramod Abcsdd	Additional Director	20 Sep 2008	Past
Pramod Abcsdd	Director	12 Nov 2011	Past
Pramod Abcsdd	Nominee Director	24 Dec 2010	Past
Pramod Abcsdd	Director	30 Nov 2011	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Surya Pharmaceutical.

Enhance accessibility to Surya Pharmaceutical's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

Profit or Loss

*******

Net Worth

*******

EBITDA

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Surya Pharmaceutical?

Unlock access to Surya Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹48,281,300,000.00

Satisfied Charges

₹16,826,900,000.00

Charges Breakdown by Lending Institutions

State Bank Of India : 3548.64 Cr
Edelweiss Asset Reconstruction Company Limited : 435.50 Cr
Punjab National Bank : 145.99 Cr
Bank Of Baroda : 125.00 Cr
Allahabad Bank : 115.00 Cr
Others : 458.00 Cr

Latest Charge Details

Date	Lender	Amount	Status
27 Feb 2013	State Bank Of India	₹546.44 Cr	Open
31 Dec 2012	Punjab National Bank	₹135.99 Cr	Open
14 Feb 2012	Idbi Bank Limited	₹60.00 Cr	Open
05 Jan 2012	Punjab National Bank	₹5.00 Cr	Open
02 Nov 2011	Punjab National Bank	₹5.00 Cr	Open

Explore comprehensive loan charge details -

How Many Employees Work at Surya Pharmaceutical?

Surya Pharmaceutical has a workforce of 0 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Surya Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Surya Pharmaceutical's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Surya Pharmaceutical

Recent Activity within the Organization

Annual General Meeting

The activity Surya Pharmaceutical Limited last Annual general meeting of members was held on 29 Sep 2014 as per latest MCA records. was completed.
29 Sep 2014
Balance Sheet

Surya Pharmaceutical Limited has filed its annual Financial statements for the year ended 31 Mar 2014 with Roc Delhi. was recorded as a recent event.
31 Mar 2014
Charges

The activity A charge with Edelweiss Asset Reconstruction Company Limited of Rs. 2.50 Cr registered on 12 Nov 2008 with Charge ID 10132676 was modified on 26 Mar 2014. was completed.
26 Mar 2014
Charges

Progress on A charge with Edelweiss Asset Reconstruction Company Limited of Rs. 3.00 Cr registered on 20 Sep 2007 with Charge ID 10068728 was modified on 26 Mar 2014. was documented.
26 Mar 2014
Charges

Progress on A charge with Edelweiss Asset Reconstruction Company Limited of Rs. 100.00 Cr registered on 13 Oct 2004 with Charge ID 90312128 was modified on 26 Mar 2014. was documented.
26 Mar 2014
Charges

The activity A charge with Edelweiss Asset Reconstruction Company Limited of Rs. 30.00 Cr registered on 19 Jan 2011 with Charge ID 10260867 was modified on 31 Dec 2013. was completed.
31 Dec 2013

Explore recent activity and updates - View Recent Activity